Corvus Pharmaceuticals Inc
NASDAQ:CRVS
Wall Street
Price Targets
CRVS Price Targets Summary
Corvus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
CRVS
is 35.7 USD
with a low forecast of 27.27 USD and a high forecast of 53.55 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRVS's stock price target?
Price Target
35.7
USD
According to Wall Street analysts, the average 1-year price target for
CRVS
is 35.7 USD
with a low forecast of 27.27 USD and a high forecast of 53.55 USD.